This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Seminoma of testis
C3_TESTIS_SEMINOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly males |
226754 |
2. Check conditionsNone |
226754 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
308 |
4. Check minimum number of eventsNone |
308 |
5. Include endpointsNone |
308 |
6. Filter based on genotype QC (FinnGen only) |
290 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Seminoma of testis
based on the number of shared cases.
Similar with more cases:
- Seminoma of testis, including Hilmo
- Malignant neoplasm of testis
- Malignant neoplasm of testis, including Hilmo
- malignant neoplasm of male genital organs
- Solid cancers, helper endpoint
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 290 | - | 290 |
| Unadjusted period prevalence (%) | 0.13 | - | 0.13 |
| Median age at first event (years) | 37.27 | - | 37.27 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 308
- Matched controls
- 3080
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
289.1
230
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
279.6
224
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
1159.8
254.5
215
6
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
1021.6
200.0
175
*
JN4BD
NOMESCO Finland
Extensive body CT
35.2
180.7
128
61
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
18.9
99.7
88
64
JN4AD
NOMESCO Finland
Body CT examination
19.5
99.5
86
60
A03FA01
ATC
metoclopramide; systemic, rectal
14.3
96.5
104
106
130
Kela drug reimbursment
Malignant tumour
+∞
86.6
79
*
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
84.3
77
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
50.4
47
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
507.5
45.5
44
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
44.9
42
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
43.8
41
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.2
40.2
68
116
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
37.2
35
*
JN3AD
NOMESCO Finland
Abdominal CT examination
6.2
35.1
69
136
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
35.1
33
*
H02AB02
ATC
dexamethasone; systemic
52.3
34.7
41
9
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
34.0
32
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.1
32.1
139
517
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
31.8
184
833
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
333.4
30.4
30
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
27.5
26
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
24.3
23
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
30.0
22.7
30
11
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
22.1
21
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
22.1
21
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
20.7
59
157
A04AA01
ATC
ondansetron; systemic, rectal
20.6
20.4
30
16
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
20.0
19
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
20.0
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
19.7
97
374
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
18.9
18
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
17.9
17
*
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
17.9
17
*
L01BC06
ATC
capecitabine; oral
+∞
17.9
17
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.7
17.5
29
47
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
16.8
16
*
L03AA02
ATC
filgrastim; parenteral
95.3
16.7
18
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
179.3
16.7
17
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
179.3
16.7
17
*
E29.1
ICD-10 Finland
Testicular hypofunction
6.5
15.4
26
43
ZXE00
NOMESCO Finland
One hour or less
2.7
15.1
120
591
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
59.7
14.9
17
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
84.2
14.7
16
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.7
14
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
14.7
14
*
N02AA05
ATC
oxycodone; systemic
3.9
14.5
47
136
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.7
13.4
47
144
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
13.0
59
213
N46
ICD-10 Finland
Male infertility
5.5
12.9
26
51
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
12.6
12
*
D29.2
ICD-10 Finland
Benign neoplasm: Testis
48.7
12.0
14
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
11.6
105
538
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.5
11
*
Y78
ICPC
Malign neopl male genital other
+∞
11.5
11
*
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
11.5
11
*
WX320
NOMESCO Finland
Spinalanesthesy
2.7
10.8
70
305
JN4CD
NOMESCO Finland
Very extensive body CT
14.9
10.6
17
12
WX402
NOMESCO Finland
General anaesthesia
2.7
10.5
65
276
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.5
10
*
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
5.2
10.4
22
45
Z51.5
ICD-10 Finland
Palliative care
10.6
10.2
19
19
D70.82
ICD-10 Finland
Drug-induced neutropenia
31.1
9.5
12
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
9.4
9
*
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
9.4
9
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
9.4
9
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.1
9.3
20
26
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
9.2
102
563
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
10.5
9.1
17
17
WZC30
NOMESCO Finland
Teaching
2.9
9.1
48
187
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
8.8
36
121
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.4
8
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
+∞
8.4
8
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
8.4
8
*
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
46.2
7.8
9
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
18.9
7.7
11
6
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
82.0
7.4
8
*
L03AA13
ATC
pegfilgrastim; parenteral
82.0
7.4
8
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
9061/3-C62.0
ICD-O-3
Seminoma, NOS, of undescended testis
+∞
7.3
7
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
7.3
7
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.7
7.3
17
38
B01AB10
ATC
tinzaparin; parenteral
3.7
7.1
23
66
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
7.1
24
71
WW500
NOMESCO Finland
Blood transfusion
9.1
7.1
14
16
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
23.1
6.7
9
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.0
6.6
13
15
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.0
6.6
13
15
7513
FHL
Test prosthesis installation
71.3
6.4
7
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.2
6.4
17
42
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
N02BE01
ATC
paracetamol; systemic, rectal
2.2
6.2
256
2135
B01AB05
ATC
enoxaparin; parenteral
2.1
6.0
67
364
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
6.0
31
119
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
161
28
119.38
304.09
7.7
2.4
98.23
2.80
u/ml
0.50
153
28
176
7
575.72
197.00
8.9
1.1
18.32
—
u/l
—
49
0
68
29
29.81
97.45
3.6
1.3
15.90
7.56
iu/l
2.32
59
20
91
86
14.60
88.12
3.2
1.4
6.96
4.20
u/l
2.30
80
72
81
5
218.63
81.57
9.6
1.0
—
—
—
0
0
259
1628
4.71
24.89
12.0
5.9
76.89
73.97
u/l
0.74
254
1537
207
1198
3.22
20.91
11.5
7.6
3.59
4.23
e9/l
5.08
186
1059
34
59
6.35
19.29
1.6
3.2
3.63
3.76
g/l
0.12
34
59
110
478
3.02
18.03
3.5
2.6
0.71
0.24
e6/l
0.51
86
365
117
532
2.93
17.60
5.4
2.0
2.35
2.34
mmol/l
0.32
108
468
118
540
2.92
17.53
3.6
2.6
113.55
155.03
e6/l
0.11
92
424
148
764
2.80
17.49
2.8
2.3
—
—
—
0
0
77
280
3.33
17.00
5.6
1.8
2.43
2.41
mmol/l
0.33
68
232
36
79
5.03
15.86
7.2
2.0
4.64
2.31
ug/l
1.70
30
64
130
666
2.65
15.10
3.7
2.7
—
—
—
0
0
193
1244
2.48
13.13
5.5
4.8
6.61
6.90
mmol/l
0.95
184
1180
68
277
2.87
12.03
3.6
2.4
0.36
0.47
e6/l
0.22
42
150
70
292
2.81
11.84
3.3
2.3
0.78
1.24
e6/l
0.38
44
165
144
868
2.24
10.75
11.6
6.5
1.20
1.20
mmol/l
0.07
113
759
135
812
2.18
9.94
9.0
4.4
36.63
36.86
g/l
0.18
124
754
129
785
2.11
9.01
10.5
6.1
1.21
1.20
mmol/l
0.41
124
723
43
163
2.90
8.56
2.4
1.8
205.51
253.66
pmol/l
1.72
43
155
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
51
4.35
8.13
4.6
3.5
0.26
0.29
u/ml
0.30
12
30
269
2228
2.64
7.75
19.8
9.2
86.83
88.61
ml/min/173m2
0.57
244
1817
42
176
2.61
6.89
3.4
2.6
—
—
—
0
0
133
904
1.83
6.15
18.4
13.3
1.44
1.28
inr
0.59
34
266
77
439
2.01
6.07
1.9
1.7
1.20
0.96
mg/l
0.30
60
320
273
2372
2.33
5.43
22.2
12.5
139.25
139.73
mmol/l
3.05
267
2311
271
2349
2.28
5.40
19.9
10.7
23.87
23.11
mg/l
0.13
226
1793
273
2391
2.25
5.01
22.5
12.5
4.02
4.01
mmol/l
0.27
266
2329
27
109
2.62
4.78
1.7
1.5
—
—
—
0
0
68
401
1.89
4.77
3.5
2.1
—
—
—
0
0
25
100
2.63
4.51
2.3
1.5
—
—
—
0
0
289
2618
2.68
4.48
14.3
8.1
32.38
33.77
u/l
0.61
284
2547
50
271
2.01
4.47
10.5
6.8
104.02
104.03
mmol/l
0.01
50
271
11
20
5.66
4.33
1.2
1.1
—
—
—
0
0
14
34
4.26
4.26
2.6
3.5
55.86
54.12
%
0.30
14
34
15
39
3.99
4.26
1.7
1.4
261.86
320.62
ug/g
—
7
20
20
75
2.78
4.08
1.4
1.6
234.55
256.04
mu/l
0.23
20
69
7
7
10.19
4.03
3.7
1.1
176.00
168.00
u/l
—
7
7
88
589
1.69
3.98
2.6
2.3
366.23
8037.52
umol/l
2.54
83
531
13
33
4.07
3.84
2.8
3.5
3.64
3.95
e9/l
0.24
13
33
128
955
1.58
3.70
3.2
2.8
0.00
0.00
estimate
-0.00
27
143
127
946
1.58
3.70
3.2
2.8
0.03
0.01
estimate
0.38
29
168
126
938
1.58
3.67
4.9
3.9
0.00
0.00
estimate
-0.00
28
160
7
9
7.93
3.57
1.3
2.7
—
—
—
0
0
49
287
1.84
3.48
2.9
1.7
—
—
—
0
0
162
1299
1.52
3.27
4.0
3.2
1.85
1.60
ug/l
0.69
144
1175
33
177
1.97
3.05
2.3
1.7
379.00
376.54
nmol/l
0.03
33
163
39
222
1.87
3.03
4.4
2.7
9.48
10.73
umol/l
0.13
33
195
37
207
1.89
3.03
6.0
3.2
0.88
1.86
mmol/l
1.01
31
173
5
5
10.13
2.99
1.2
1.2
12.60
11.68
u/l
—
5
5
37
209
1.88
2.95
6.1
3.2
5.86
5.86
kpa
0.00
37
202
40
234
1.82
2.86
4.7
2.4
25.20
25.87
%
0.11
34
202
24
119
2.10
2.74
1.9
1.4
—
—
—
0
0
10
29
3.53
2.71
2.6
1.5
—
—
—
0
0
13
49
2.73
2.66
2.4
1.5
—
—
—
0
0
14
55
2.62
2.65
3.8
1.5
—
—
—
0
0
33
190
1.83
2.49
4.8
2.2
25.07
293.70
u/l
0.55
27
162
10
32
3.19
2.46
1.4
1.6
—
—
—
0
0
294
2781
2.26
2.40
31.5
15.1
41.41
42.78
%
3.38
282
2605
5
8
6.33
2.38
1.2
1.5
4.66
2.65
mg/l
—
5
8
108
843
1.43
2.29
3.3
3.2
69.35
59.42
ng/l
0.09
77
555
18
88
2.11
2.16
2.2
2.9
4.72
4.75
pmol/l
0.03
13
77
178
1538
1.37
1.99
3.3
3.7
13.35
8.89
mm/h
2.19
162
1439
86
665
1.41
1.88
3.5
2.5
56.83
65.37
u/l
0.58
77
634
6
17
3.58
1.84
1.0
1.3
0.17
0.19
nmol/l
—
6
12
6
17
3.58
1.84
1.5
1.9
—
—
—
0
0
71
535
1.43
1.79
2.6
3.0
965.00
1116.19
ng/l
0.21
61
432
6
18
3.38
1.75
1.0
1.1
—
—
—
0
0
97
779
1.36
1.67
3.5
2.8
—
—
—
0
0
10
41
2.49
1.66
2.6
1.6
—
—
—
0
0
10
41
2.49
1.66
2.6
1.6
—
—
—
0
0
55
402
1.45
1.63
2.3
2.0
2.72
2.92
mg/l
0.30
46
339
27
169
1.66
1.58
5.3
2.5
5.96
4.50
kpa
1.78
27
162
210
2284
0.75
1.56
4.1
3.9
6.01
6.03
mmol/l
0.08
190
2106
25
154
1.68
1.55
2.4
1.9
58.75
67.88
ml/min/173m2
0.38
12
59
230
2466
0.73
1.51
4.0
4.0
1.27
1.28
mmol/l
0.18
215
2328
6
21
2.89
1.51
1.0
1.0
—
—
—
0
0
5
16
3.16
1.44
5.6
1.9
—
—
—
0
0
20
119
1.73
1.41
1.5
1.5
—
—
—
0
0
45
327
1.44
1.39
2.0
2.0
—
—
—
0
0
6
23
2.64
1.37
3.7
2.4
506.83
727.17
e6/l
—
6
23
6
23
2.64
1.37
1.0
1.5
—
—
—
0
0
6
23
2.64
1.37
1.0
1.1
—
—
—
0
0
33
226
1.52
1.36
11.8
10.3
0.69
1.38
mmol/l
0.54
26
183
235
2500
0.75
1.33
4.3
4.4
2.84
2.86
mmol/l
0.11
225
2353
31
211
1.52
1.31
2.7
1.7
—
—
—
0
0
6
24
2.53
1.31
1.0
1.1
—
—
—
0
0
21
131
1.65
1.27
14.5
10.3
0.65
0.71
%
0.28
21
131
21
322
0.63
1.26
1.1
1.2
13.26
29.10
iu/ml
—
7
94
31
215
1.49
1.21
2.7
1.8
—
—
—
0
0
21
133
1.62
1.21
14.5
10.2
1.13
1.65
%
2.04
21
133
42
310
1.41
1.20
1.8
1.7
1158.99
1183.66
nmol/l
0.07
28
254
233
2472
0.76
1.19
4.0
4.1
4.65
4.63
mmol/l
0.07
219
2340
8
38
2.13
1.19
1.9
1.2
—
—
—
0
0
8
38
2.13
1.19
1.9
1.2
—
—
—
0
0
6
26
2.33
1.19
1.5
1.0
—
—
—
0
0
8
39
2.08
1.16
1.1
1.3
—
—
—
0
0
5
20
2.52
1.15
3.6
1.5
—
—
—
0
0
16
96
1.70
1.12
3.3
2.8
—
—
—
0
0
47
362
1.35
1.06
1.9
2.1
—
—
—
0
0
5
22
2.29
1.04
1.0
1.1
257.60
297.65
mg/l
—
5
17
7
35
2.02
1.00
1.0
1.6
—
—
—
0
0
5
23
2.19
0.98
3.6
1.5
—
—
—
0
0
0
29
0.00
0.98
0.0
1.8
—
—
—
0
0
87
738
1.25
0.96
1.7
1.8
95.98
92.87
pmol/l
0.25
51
411
6
27
2.25
0.94
1.5
1.4
—
—
—
0
0
17
110
1.58
0.92
2.1
1.9
64.21
68.14
g/l
1.16
17
98
85
723
1.24
0.92
2.3
2.3
0.73
0.66
ug/l
0.41
57
386
227
2394
0.80
0.91
3.6
3.7
1.46
1.42
mmol/l
0.32
213
2253
89
762
1.24
0.90
3.9
2.4
204.99
163.97
ug/l
0.90
80
705
6
29
2.09
0.90
3.5
1.7
—
—
—
0
0
6
29
2.09
0.90
3.5
1.7
—
—
—
0
0
11
64
1.75
0.87
1.2
1.1
—
—
—
0
0
11
64
1.75
0.87
1.2
1.1
—
—
—
0
0
8
45
1.80
0.85
1.6
1.4
—
—
—
0
0
11
66
1.69
0.79
1.2
1.1
—
—
—
0
0
0
28
0.00
0.76
0.0
1.4
—
350.00
—
0
5
17
116
1.49
0.76
2.6
2.1
0.56
0.62
%
0.30
17
116
7
39
1.81
0.73
1.3
1.6
—
—
—
0
0
10
158
0.62
0.72
1.6
1.7
—
—
—
0
0
40
493
0.78
0.72
1.4
1.2
7.63
1.19
u/ml
0.59
13
154
7
41
1.72
0.70
2.0
1.2
—
—
—
0
0
5
29
1.74
0.64
1.2
1.4
—
—
—
0
0
5
30
1.68
0.61
1.0
1.2
—
—
—
0
0
46
384
1.23
0.60
1.5
1.5
17.73
18.52
nmol/l
0.16
40
331
112
1017
1.16
0.58
3.0
3.1
22.10
23.85
%
0.62
50
370
12
81
1.50
0.58
5.8
10.7
1.98
1.60
%
0.27
12
75
8
55
1.47
0.56
1.8
1.4
—
—
—
0
0
8
55
1.47
0.56
1.8
1.4
3.46
3.70
g/l
—
8
47
8
55
1.47
0.56
1.8
1.4
7.24
7.06
g/l
—
8
47
57
492
1.19
0.54
3.3
3.0
0.00
0.03
estimate
0.68
26
151
6
38
1.59
0.54
1.2
1.2
—
—
—
0
0
10
66
1.53
0.53
1.1
1.8
—
—
—
0
0
9
64
1.42
0.52
1.1
1.5
—
—
—
0
0
176
1855
0.88
0.49
3.2
3.2
54.92
48.93
u/l
0.32
166
1770
7
45
1.57
0.49
2.0
1.3
9.20
11.11
g/l
—
7
37
7
49
1.44
0.46
1.0
1.1
—
112.00
—
0
14
12
86
1.41
0.45
3.8
2.8
—
—
—
0
0
31
259
1.22
0.42
3.7
4.3
29.58
29.58
%
0.00
24
197
5
32
1.57
0.42
1.0
1.1
9.18
7.82
mmol/l
—
5
27
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
5
35
1.44
0.39
1.0
1.1
—
—
—
0
0
9
66
1.37
0.38
1.1
1.3
—
—
—
0
0
30
253
1.21
0.38
7.1
6.8
—
—
—
0
0
61
676
0.88
0.37
4.0
4.3
7.35
10.40
mg/mmol
0.44
41
476
5
76
0.65
0.36
3.6
2.4
—
—
—
0
0
6
44
1.37
0.34
2.0
1.3
0.18
0.46
g/l
—
6
39
210
2167
0.90
0.33
5.8
5.3
39.28
39.96
mmol/mol
0.45
191
2054
12
92
1.32
0.32
2.9
2.8
22.82
24.76
mmol/l
1.00
12
86
7
52
1.35
0.31
1.9
1.4
2.99
2.85
g/l
—
7
44
29
334
0.85
0.30
1.8
1.7
—
—
—
0
0
8
62
1.30
0.28
1.0
1.2
—
—
—
0
0
5
72
0.69
0.26
1.0
1.1
—
3.82
—
0
11
181
1750
1.08
0.26
2.8
3.0
—
—
—
0
0
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
5
42
1.19
0.21
2.2
1.2
35.72
39.17
g/l
—
5
34
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
13
108
1.21
0.20
1.2
1.2
—
—
—
0
0
17
149
1.15
0.16
2.6
3.4
103.88
168.63
ng/l
0.76
17
132
42
391
1.09
0.15
1.6
1.7
390.91
11628318.70
pmol/l
0.50
32
344
12
103
1.17
0.14
1.1
1.0
—
—
—
0
0
76
732
1.05
0.11
2.7
2.2
74.63
71.87
nmol/l
0.34
69
666
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
153
1504
1.03
0.08
3.5
2.8
15.01
14.94
pmol/l
0.11
138
1374
8
74
1.08
0.07
2.4
4.8
—
—
—
0
0
56
576
0.97
0.05
1.8
1.7
1.54
1.59
mmol/l
0.19
45
493
47
456
1.04
0.05
1.5
1.4
—
—
—
0
0
41
417
0.98
0.01
3.6
3.6
167.75
1001.33
ng/l
1.97
32
308
63
623
1.01
0.01
2.3
2.1
128.14
237.78
u/l
5.46
63
587
197
1969
1.00
0.00
3.9
3.4
1.94
2.50
mu/l
0.44
176
1819
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
14.58
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
1.30
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
-0.00
0.0
3.4
—
115.00
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
56
0.89
-0.00
1.4
1.4
81.16
192.23
pmol/l
—
5
56
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_TESTIS_SEMINOMA – Seminoma of testis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).